McBride plc (MCB) Earnings Call Transcript & Summary

February 26, 2026

London Stock Exchange GB Consumer Staples Household Products earnings 51 min

Earnings Call Speaker Segments

Moderator

operator
#1

Good day, everyone, and welcome to today's webinar hosted by McBride, where we'll be discussing the interim results they announced recently and also spending a bit of time on what lies ahead for the business. A couple of housekeeping items before we begin. This session is being recorded, so if you happen to miss anything, you'll be able to watch it again. We're very eager to take your questions once the formal presentation wraps up, and you can send those in using the question button on your screen. The presentation deck that the boys will be walking through is already up on the McBride Investor Relations page, together with plenty of other helpful materials. We're delighted to welcome back CFO Mark Strickland and CEO Chris Smith, and I'll now hand things over to you, Chris, if you'd like to kick off the presentation.

Christopher Ian Smith

executive
#2

Thanks, Andy. Good morning, everyone, and welcome to the presentation and deck for our Interim Results covering the six months that ended on the 31st of December, 2025. On the next slide, please, Andy — today I'll go through the headlines as well as an update on how the business is progressing, and after that I'll pass things to Mark, who will walk you through a more detailed look at some of the financials. Then I'll return myself for the outlook, and following that we'll move into questions, just as Andy mentioned. Before I walk through the various slides, I want to note that three key themes really capture what these past six months have been about. First, we kept delivering strong financial and operational performance — now for the 3rd consecutive year. Second, we passed a significant milestone on our transformation journey, with our first SAP go-live in November. Third, we clearly demonstrated a balanced approach to capital allocation, supporting both short-term shareholder returns and longer-term value creation through business investment. Next slide, please, Andy. This marks the sixth set of results — interims and finals — that I've presented in which the group has reported profitability levels at double the historic average, cementing our new financial strength and our optionality to deploy resources in support of future growth in line with our ambitions as we set them out at our Capital Markets Day about two years ago.

Christopher Ian Smith

executive
#3

The market keeps shifting toward the private label offering we provide, and the newest figures show private label share has begun climbing past recent record highs, which gives McBride a strong base from which to keep prospering. Our divisional and central teams keep pushing the business forward, closely aligned with their strategies, backing our customers as our private label proposition grows to deliver value for retailers and consumers alike. McBride's private label volumes carried on growing over this past period, though at somewhat lower levels than the past two years showed, with total sales revenue up just under 1% to GBP 475 million. We have locked in a solid pipeline of new business wins that should begin in the second half year, creating positive momentum as we leave financial year 2026. We head into the next financial year, 2027. Our excellence and transformation agenda has carried on at pace across these past six months. Productivity and other operational improvements, along with tight management of overheads, have kept margins steady despite competitive pricing pressures and inflationary pressures. EBITDA, EBITA, and PBT all stay consistent with the first half of last year, with EBITDA margins just under 9% for the first half and the full year anticipated to be over 9%.

Christopher Ian Smith

executive
#4

I'm delighted to be able to verify that our first SAP S/4HANA go-live in the U.K. was finished successfully during the period, following two years of preparation and design. As we upgrade McBride to the latest best-in-class ERP systems, this multi-year program serves as the platform for future efficiency and operating excellence. A balanced approach to capital allocation has been supported by our continued strong profit levels and cash generation. During the period, nearly GBP 13 million of shareholder returns were deployed through reinstated dividends, the share buyback program, and share purchases aimed at reducing future dilution from employee share awards. The rise in our overall share price since September 2025 equates to a market cap increase of approximately 40%. Capital expenditure rose in support of growth, efficiency, and transformation programs. The group stays active in weighing all options for deploying capital as it seeks to grow shareholder value. I'll now move on to give an update on a series of key business progress topics. At our Capital Markets Day in February 2024 — next slide, please, Andy — we laid out a number of key ambitions against which to measure our progress. At this midpoint of FY 2026, we remain committed to these key targets over the coming years, and our progress since 2024 continues to perform in line.

Christopher Ian Smith

executive
#5

While our volume growth has been somewhat slower over the last six months, cumulatively it remains comfortably ahead of the target we set in 2024. We have an encouraging set of contract wins that begin in the second half, and these are expected to support improved growth rates into FY 2027, along with a number of other material growth options currently in development. Our EBITDA margins sit consistently at around the 9% level, with another 1% needed to get to our 10% ambition, and that is almost double the historic level of 5%. At the Capital Markets Days in February 2024, we said shareholders should expect some minor variability in this ratio, since modest swings in input costs will either benefit or hit the group's profitability between periods. Our debt position remains well within our targets. That is after nearly GBP 13 million deployed over the past six months for shareholder returns. Our long-term committed facilities and liquidity availability give us ample scope for further capital deployment in pursuit of our strategic ambition. ROCE remains well above the targets, and our work on excellence and transformation is delivering tangible improvements that support and develop the robust platform the group needs for long-term success.

Christopher Ian Smith

executive
#6

Now turning to a report on the markets we serve. Here we show the standard panel data that comes to us every quarter. Just to remind you, this data reflects 12 months trailing value and volumes. It spans the top five economies in Europe, every bricks and mortar retailer, and all the household categories we supply. We've now been monitoring this data for more than four years. After substantial growth between 2022 and 2024, private label market share by volume — the green line on that chart — leveled off during the last 12 to 18 months. This newest data insight, though, indicates that the total market overall keeps expanding slightly toward the low end of our 1.1x-2x, sorry, 1%-2% projections, with private label once again beating brands in every category, as private label volume share has now reached 36.1%, an increase of 0.3% versus the prior four quarters. We'll watch the coming two data drops to see whether this additional gain holds, but this latest data supports our belief that the more probable path is continued share gains for private label rather than a return to pre-2022 levels. Turning to the divisions, I'll give a quick update from each of the businesses.

Christopher Ian Smith

executive
#7

Moving to the next slide, Andy. Mark will go through the financial performance afterward, but overall we've witnessed solid profit improvement in Unit Dosing and aerosols, while Liquids and Powders came in a bit softer. The Liquids division has been extremely busy during this stretch and simultaneously needed to manage the initial go live of the S/4HANA program at the U.K. liquid site. Volumes for the division came in higher across the board, particularly from contract manufacturing, which rose 9%, while private label was flat. Uncertainty surrounding the rollout of the EU Deforestation Regulation, or EUDR, has created pressure on some raw materials, most notably within the Liquids business, where palm oil derivatives are actively used. The division did experience modest material cost increases in a market where increases that small really cannot be passed through. Still, the business was vigilant, naturally, when it came to cost management and product engineering, and it handled its margins very effectively during the period. Anticipating growth ahead, particularly from laundry, the division kept investing in capacity and new packaging formats so it could secure new business going forward. In Unit Dosing, we delivered a strong operational performance, helped by the benefits of our Flexcellence program, through which we now make sure that every one of our pod formats can be supplied in all the various packaging formats customers require, producing output and headcount efficiencies.

Christopher Ian Smith

executive
#8

Looking at the total picture, volumes came in below where they were a year ago, though that decline sits entirely within contract manufacturing, where a contract we lost last year fully annualized as of December. On the private label side, volumes held steady, with gains from some customers offset by losses at others, plus a handful of product launches that slipped. We've had strong wins in recent tenders, and those are slated to come on stream during the second half and into early FY 2027, which gives us solid growth prospects going forward. Overall, the Powders business keeps beating its strategic targets. Demand for private label laundry has stayed stable, and private label share is climbing while branded volumes keep declining. In Powders, total volumes for our division at McBride were roughly flat, with private label overall a touch softer than our contract business, which accounts for about 40% of revenues in this division. As in our other divisions, recent wins — again expected to launch over the next six months or so — will deliver good growth in future periods. Meanwhile, tight operational control and focus have kept margins stable, and some automation capital investment has come in, which is helping push margins up. Our aerosols team has once again delivered this year. Volumes rose 15% and now sit close to the 100 million cans target. The very strong growth in Germany came about through focus over the past few years on this targeted market.

Christopher Ian Smith

executive
#9

We've largely finished putting GBP 2.5 million into a new production line, and that's giving us the capacity to push beyond the 100 million cans mark. Now, turning to Asia. The year was somewhat mixed for us there: private label sales into Southeast Asia came in weaker than we'd expected, Australia was quieter, and we lost one part of a traded good supply from our European business. The outlook is brighter, though — our first household wins in Australia for products made in Malaysia should launch in roughly the next month, and we're in discussions about a series of new contract manufacturing opportunities. Moving to an update on the transformation program, or the excellence agenda as I call it, which has kept moving quickly throughout the period. After more than two years of setup and design work by the SAP team, we successfully went live with the new global template, with the first launch at the beginning of November in the U.K. business and corporate center. It's pleasing to report that the business is running as usual, with a little disruption during the first few weeks to our warehouse operations, where the systems were functioning but we became limited by capacity.

Christopher Ian Smith

executive
#10

We did lose a handful of sales during that brief window, and we estimate the value at roughly GBP 3 million, with an EBITDA impact of about GBP 1 million. That issue was sorted out fast, and since then the business has posted record output and shipment days. Attention has now shifted quickly toward lessons learned, and we are well along in planning the wave two rollout of this new global template, so that we keep up the pace toward the efficiencies and benefits that will come once more locations sit on this new platform. The remaining three major programs within the wider plan — service, commercial, and productivity — have all reached business as usual, with the service program finishing in September and the Commercial Excellence project wrapping up in December. Both are delivering solid results, with better processes now in place across the business and clear KPI gains. Next slide, please. The last six months have shown how flexibly the group approaches capital allocation. Given the strength of the group's trading position and its funding capacity, we have put close to GBP 13 million into shareholder returns. At the AGM in December, shareholders approved the board's recommended restart of annual dividends, resulting in a payment of GBP 5.2 million in November.

Christopher Ian Smith

executive
#11

Given a market valuation that sits far beneath what the board believes the group ought to be worth, we launched two value initiatives during the autumn. The first involved spending GBP 6.4 million to purchase shares at an average price of GBP 1.26 via the Employee Benefit Trust, or EBT, so that the EBT would hold sufficient shares to cover future incentive awards anticipated to vest over the coming two years. Ordinarily, new issue shares would be used to satisfy these awards, which would dilute total shares in issue — that is why we took this step, which is worth roughly 0.7 pence per share in reduced dilution within future EPS calculations. The second initiative was a GBP 20 million share buyback scheme, which the board kicked off in December. With just one month of purchasing before the half year closed, GBP 1.3 million had been deployed by 31st of December. A strong recovery in the share price and in our market capitalization — up approximately 40% since the final results in September last year — has been supported by all of these actions. As a reminder, that is a significant rise, and we are still only trading on a 4.9x EV/EBITDA multiple. At this point, I will now hand things over to Mark, who will take you through a more detailed financial review.

Mark Strickland

executive
#12

Thanks, Chris, and good morning, everyone. McBride has turned in another solid set of results. Alongside those good results, the business has shown a balanced approach to capital allocation — prioritizing short-term shareholder returns while retaining the flexibility to fund our longer-term ambitions. As a result, I remain hugely optimistic about what the business can keep delivering for its shareholders into the future. Turning to the financial highlights. Group revenues rose by GBP 3.8 million, up 0.8% on an actual basis, but in constant currency terms they slipped slightly, down 2.1%. Private label and contract manufacturing volumes both grew, while McBride branded volumes were slightly weaker and declined. Adjusted operating profit dipped slightly to GBP 31.5 million. Absent the SAP impact, adjusted operating profit would most likely have risen slightly. In prior years, profit levels have been sustained through good margin management and control of overhead costs. Adjusted EBITDA of GBP 41.8 million was on a par with the first half of the previous year. Earnings per share fell to 10.8 pence per share, mainly because of a particularly tough prior-year comparator on taxation, which was 25% in last year's first half versus 30% this year.

Mark Strickland

executive
#13

For the full year 2026, we anticipate taxation will be roughly consistent with the rates we saw in the prior full year. Across the past three years, we've steadily reinforced the balance sheet by generating cash and keeping debt in check, and this period follows that same pattern. In the first half of the financial year, free cash flow came to GBP 24 million generated, while net debt rose only marginally, reaching GBP 120.6 million, even after nearly GBP 13 million went out for dividends, the EBT, and share buybacks. That demonstrates the business, via its proactive approach to capital allocation, can balance short-term returns to shareholders while preserving a flexible platform for future investments in growth, whether organic or through M&A-type activities. Turning to financial performance. This slide examines group and divisional performance on an actual and a constant currency basis. Three main drivers sat behind the actual revenue growth of 0.8%. First, volume; second, price and mix; and third, FX. Volume growth of 0.4% came from contract and private label volume growth, together with continued growth in aerosols. As I mentioned earlier, that was offset by a decline in McBride branded volumes.

Mark Strickland

executive
#14

The second effect involved price and mix, and there were two factors involved. First, some pricing pressure has existed, but product re-engineering and continuous margin management have mostly compensated for it. Let me go into more detail on that. Put differently, even if the selling price is lower, profitability frequently ends up similar to that of other products, since these tend to be lower cost format products. Second, more sales of lower value products occurred during the first half of the financial year than in the prior financial year. FX formed the third and last impact, chiefly as the pound-euro exchange rate shifted toward EUR 1.15 to the pound. Turning to the divisional review for Liquids. With revenue of GBP 269 million, the Liquids division accounts for roughly 57% of the group. As Chris mentioned earlier, November and December saw a limited impact from the SAP S/4HANA Go Live. Even so, volumes rose 0.1%, with most markets stable and only France showing a slight decline. Competitive pressures, inflation, and some marginal raw material increases that could not be passed on to customers, given their small size, weighed on margins. The division nevertheless delivered an adjusted operating profit of GBP 17.7 million, a return on sales of 6.6%.

Mark Strickland

executive
#15

We keep putting money into this business for the long term. Now turning to Unit Dosing. During the first half of the financial year, revenue from the Unit Dosing division came in at GBP 116 million. Measured by revenue, Unit Dosing accounts for roughly 24% of the group. Contract manufacturing volumes were softer in the first half, and the outlook points to good year-on-year growth in overall volume during the second half of the financial year. The division posted better profitability in the period, at GBP 12.5 million, thanks to continued production efficiencies, the gains from transformation, and ongoing tight control of overhead costs. At 10.8%, the division's return on sales marks a pleasing step up from the prior year. Lastly, the Unit Dosing division, through its Flexcellence initiative and the breadth of formats it can now offer — its soft pods portfolio, for instance — remains well positioned to keep winning business in future tenders. Now on to Powders. At roughly 9.5% of our overall revenue, the Powders division operates in a market that is steadily declining overall. Sales of GBP 44.9 million fell short of expectations, hit by slightly softer private label demand, mainly in the U.K., along with delayed launches of new contracts and shifts in product mix.

Mark Strickland

executive
#16

Adjusted operating profit fell by GBP 1.1 million, landing at GBP 3 million, with the main driver being the lower revenue mentioned earlier. That said, thanks to solid cost control, operational efficiency, and — once again — product cost engineering, the division still turns in a healthy return on sales, consistent with what we expect over the medium term. And last, as is the case with Unit Dosing, this business segment has a solid pipeline for future growth. Turning now to aerosols and Asia Pacific. Together, aerosols and Asia Pacific account for roughly 9.5% of the group's revenue. Our aerosols division has been a tremendous success story across the past few years. The first half of 2026 was no exception. Volumes rose by around 14.6%, while revenue climbed 18.1% to GBP 33.9 million, producing an adjusted operating profit of GBP 2.1 million and moving us closer to our midterm return on sales ambitions. This growth is underpinned by major contract wins in Germany, along with personal care launches in other parts of Europe. The first half of financial year 2026 also brought a continuation of the substantial investments aimed at expanding capacity at the Rosporden site in France. That investment remains on track to be completed in the second half of this financial year. Asia Pacific, our smallest division, has felt the effects of weak private label demand in Southeast Asia and has needed to concentrate on managing costs in order to protect its profitability.

Mark Strickland

executive
#17

Even so, private label household in Australia has moved forward nicely. While it's still an incubator business at this point, we continue to feel confident about meaningful opportunities there, which means we should be able to expand that business across the coming couple of years. Turning to costs. Input costs stayed flat through the first half of the 2026 financial year — benign on the whole. The chart on the left shows they are still considerably above where they stood in 2021. Inflation hasn't gone away, and certain costs continue to climb, though more slowly than they did across the last few years. So McBride's ongoing emphasis on managing margin has been essential in delivering this solid set of results. That steadiness of performance leaves McBride, as a group, very well positioned to keep underlying profits going in the years ahead. Like most businesses, technology stays a central focus, and McBride has in fact taken up new technology, convinced it will serve as a key positive differentiator down the road. Chris has noted that wave one of the S/4HANA project went live successfully in the U.K., and we anticipate finishing the rollout during the 2028 financial year, consistent with what we said when we launched the project.

Mark Strickland

executive
#18

We keep putting money into our data analytics team, and we’re seeing the payoff. A concrete illustration of that capability is some of the market analysis information Chris showed you earlier in his presentation. On overheads, as you’d expect, our attention stayed on optimizing costs. We’ve kept overhead costs under tight control, lowering both distribution and administrative costs as a % of revenue. Turning to other financials. Interest was broadly flat year-on-year, and interest cover was likewise broadly flat. Exceptional costs came to GBP 2.4 million, tied to the SAP S/4HANA implementation and an ongoing review of the group's strategic growth options. On taxation, the effective tax rate for the first half was 30%, versus 25% in the first half of 2025, but a full year rate of 32% in 2025. Actual tax paid in half 1 was GBP 1.8 million, compared with GBP 7.1 million the previous year, as cash payments normalized to payment of in-year liabilities only, rather than FY 2025, when there was an element of catch-up from the financial year 2024. Capital expenditure levels, at GBP 14.8 million, were up from GBP 12 million the previous year as the business kept investing in the future.

Mark Strickland

executive
#19

The group is expected to spend roughly GBP 30 million to GBP 33 million across the current full year, and expenditure should stay at approximately GBP 30 million in the year after that, then decline as the SAP project wraps up. Now, turning to net debt. As I mentioned at the outset of my presentation, the business keeps producing robust cash flows, which has kept net debt in check, with a modest rise to GBP 1.206 million. Core liquidity is strong, at about GBP 135 million of headroom, and there is also an untapped EUR 75 million accordion facility, which preserves optionality for future decisions on capital allocation. To wrap up, the business is still being run well. Our shareholders get good value from the share buyback. Thanks to the successful implementation of the SAP global template, future implementation risk is much lower, and balance sheet strength still gives the business optionality. Thank you. I'll hand you back to Chris now.

Christopher Ian Smith

executive
#20

Thank you, Mark. As you've heard throughout the presentation, business momentum is good, and the first months of our second half have seen volumes in line with our estimates, with the start-up of new business wins still on track to meet the timelines required to meet our second-half targets. As mentioned earlier, the private label market overall is expected to maintain its strong position of recent years, with some potential for further growth if private label continues to grow share. We expect material costs to remain stable, possibly with some weakening of pressure for natural alcohol-based materials and recycled content plastics. Other inflation is being managed through tight overhead control and vigilance on allowing new costs to creep in. Our teams have delivered really well on all our transformation initiatives, and the recent success of such a major milestone of the first SAP go live gives confidence about the rollout of our global template to all other locations over the next two-three years. This should be seen as a big risk reduction point for investors, and the focus will turn to driving the expected efficiencies, enhanced insights, and better decision support. At this stage, nearly two months into the second half, I'm pleased to confirm we expect to deliver full year results in line with analysts' expectations.

Christopher Ian Smith

executive
#21

Given our normalized funding position and the sustained elevated profitability we're seeing, the reset, resilient, and stronger McBride is now in a position to look at a variety of ideas for creating future value that would back our midterm ambitions — growing the group further and delivering even higher margins. Thank you. I believe Andrew is ready for questions.

Moderator

operator
#22

Thanks a lot, gentlemen. Another very thorough and impressive showing, which is great to see continuing. There are already plenty of questions submitted, so let's get started. To begin with, on S/4HANA and Wave One: could you say a bit more about what you've taken away from that process? It's rare for any systems integration to go through without a few teething problems. We also have a related question: what was the reason for rolling it out in Liquids first?

Mark Strickland

executive
#23

Should I take that question?

Moderator

operator
#24

Right.

Mark Strickland

executive
#25

We picked up a great deal from this exercise—way too much to cover in a 30 or 40 minute session like this. The main lesson is volume testing. That means testing at volume, especially in warehousing. A really narrow problem cropped up in what we call a VNA, a pick and dispatch area. Third party logistics performed fine, third party warehousing performed fine, yet Middleton has a really particular requirement for moving product into and out of what are called very narrow aisles, and we didn't run enough volume through that. In the end it worked, but we got somewhat capacity constrained. Testing at volume was a major takeaway. Training came a bit late in the day, and we also know we don't want to do it too early. We also focused on what's called the happy path—when everything goes right. With hindsight, we probably ought to have focused somewhat more on what's called the unhappy path—how do you fix things when they go wrong? On the whole, I'm really pleased with the implementation. There are plenty of peripheral lessons. There always are. I think the way the entire team came together really showed the McBride ethos and the McBride values—both the project team and the site team; it was a joint effort.

Mark Strickland

executive
#26

I’m sorry—could you repeat the second part?

Christopher Ian Smith

executive
#27

The question is: why the U.K.?

Mark Strickland

executive
#28

So why the U.K.?

Moderator

operator
#29

Regarding the U.K.

Mark Strickland

executive
#30

Basically, the reason is that we had, or we have, two SAP instances — one in the U.K. and one in Europe. The U.K. had just two sites, so shifting it over to the new SAP was the easiest option. We would have needed to migrate 12 sites, you know, and we'd have finished up with three separate SAP instances, while by moving the U.K. we stayed at just two instances. It was a fairly straightforward call, honestly.

Moderator

operator
#31

Got it, thanks. Several questions have come in regarding inorganic growth. Chris, you mentioned the low EV/EBITDA rating, even though it's getting better. One question we have is: does that pose an obstacle when it comes to pursuing bigger acquisitions?

Christopher Ian Smith

executive
#32

Yes, absolutely — when it was sitting at a multiple of three and a bit times, that was a very big obstacle. I mean, look, the amount of M&A we could be considering — and actually, inorganic growth can stretch to contract manufacturing chances too, where capital might be required. You might not require new sites; you might simply need to put new capital into your current facilities. You know, the value ranges we're discussing are all within reach given our debt facilities. Look, there are plenty of benchmarks in the industry right now regarding what buyers are paying for home care businesses — the Reckitt transaction with Advent recently, for instance. We're also aware there was one in Spain recently. We have a — you know, I think the industry is sort of converging on what that multiple range should be. I suppose that having brought the share price back up somewhat and delivered better value for shareholders, with our rating today, you know, we're getting nearer to making it not so significantly hard, if you like. Look, I think in most cases on the M&A side, the synergy benefits can come quickly, and so, you know, we'll also focus on the speed at which we bring that multiple down after acquisition through synergies.

Christopher Ian Smith

executive
#33

Yeah, we’re very aware of how tough things are with multiples. I think we’ve closed that gap somewhat. I think we—you know—we understand the price we have to pay. I don’t think shareholders—we’re not going to go out there and pay eight or nine times for anything. That’s not something people should worry about.

Moderator

operator
#34

When you think about possible targets, in an ideal world — which clearly isn't the one we're in — which segment or region would you most want to grow in, or where would you like to find bolt-ons that could be added onto the structure as it stands today?

Christopher Ian Smith

executive
#35

Well, look, I mean, our M&A targets and contract manufacturing will definitely be aligned, frankly, with the company's key missions and strategies, right? Look, we're a business focused on Europe, you know, I don't suspect we'll suddenly be acquiring things in the U.S. or South America. Our focus is in Europe. Obviously, there's a bit of focus in Asia around how we grow that business, that incubator business Mark mentioned, to make it more substantial, a little like what we've done with aerosols, right? We've now got that business to be credible and valuable to us, and of course, we're on the same mission with Asia. Look, the bulk of it will be in Europe, and we spoke strongly about the bulk of our activities being in the higher margin, high capability categories where we're strong. You know, laundry, dish, that sort of area, are probably the main focal areas.

Moderator

operator
#36

Good. You've actually jumped ahead to something I was going to ask about, which is contract manufacturing. Is that yet another area of the business that's pretty competitive right now, and one where you'd still want to add capacity and scale?

Christopher Ian Smith

executive
#37

Absolutely, yes. I mean, we've made it very clear that our goal is for contract manufacturing to account for 25% of the business. We're not looking to achieve that by reducing private label — we want to get there through growth in contract manufacturing. In our view, 25% is the appropriate level for us to have what you might call a core layer of stable, long-term partnerships or relationships with certain branders, for categories and volumes that might not be efficient for them to produce themselves. Yes, definitely, that's a central element of what we're focused on, and it's another possible way to deploy capital to build long-term value. Absolutely. There's, you know, a fair amount happening in the industry right now, so we, you know, we're pretty occupied with potential opportunities. Nothing is certain, you know, there is, there's perhaps more going on at the moment than we've seen in some time potentially out there.

Moderator

operator
#38

Sure, that ties into a question on capital allocation, and maybe gives you a chance to explain how long it can take for certain acquisitions to bear fruit. The question that came in is: "How do you weigh the value in your own shares against doing more buybacks versus putting that capital toward non-organic growth?"

Christopher Ian Smith

executive
#39

Okay, so we are always monitoring and evaluating this, naturally. I mean, we prefer to think in terms of—we do believe there are moments when near-term requirements exist, as is the case with the share buyback at present and buying shares for the EBT. We understand that our investors appreciate the dividend stream, and we view the share and the equity as a combined proposition involving, you know, index re-rating plus cash from sources such as dividends and other shareholder returns. We also understand that we, the industry, and I would say the McBride platform must grow over the medium and long term, and we recognize within this industry that consolidation of the space for the benefit of retailers—I think the sustainability journey and regulatory environment is going to get tougher—and you need to be larger and larger in this industry to lead. I think, you know, we have all of those factors at play, and we have, you know, active conversations. I suppose, you know, the board's judgment here at each juncture is: what is the right decision? I think we will—you know, we've shown over this last period a reasonably agile and, you know, what's the word?

Christopher Ian Smith

executive
#40

It's a mixed approach, actually — "variable" isn't the right word there. We're examining every option.

Moderator

operator
#41

Right. That's really where financial health pays off — and a balance sheet that gives you flexibility.

Christopher Ian Smith

executive
#42

I appreciate the clarification.

Moderator

operator
#43

To adapt to opportunities, I would think. You know, perhaps, a couple of questions for you, Mark, on costs. Impressive progress, and the question is, you can't, ad infinitum cut costs as a % of revenues. What do you think is a realistic target in the medium term as the transformation benefits all work their way through?

Mark Strickland

executive
#44

Yeah, I think that’s a really good point. Ultimately, there are times when it genuinely makes sense to spend more on the business, because what you get back from that additional expense is much greater than what it costs. I don’t have a specific target in mind, since it really depends on the various segments of the business, you know? Different segments are going to have different overhead requirements. As we put money into technology, my hope is that decision-making speeds up considerably, and that the expense involved in making those decisions also declines. And let’s not forget that software providers tend to raise their license fees too when you’re using their software. It’s a balancing act. I don’t have a particular ratio or a particular cost figure in mind, but what I consistently emphasize is cost optimization rather than cost saving, because we can’t save ourselves rich. We do need to invest in this business, and we do need to grow it. Saving will keep us in business, but I don’t know anyone who has ever saved themselves rich.

Moderator

operator
#45

Those are wise words, wise words. To speak directly to input costs, there's a comment we've noted, and it's quite accurate, that you don't participate in supplying precious metals or rare earths, which right now can put certain businesses in a particularly painful spot. Is there anything in the supply chain that worries you more, perhaps around shipping costs or similar matters, as you transport some of the basic commodities to your sites?

Mark Strickland

executive
#46

Right now, to be honest with you, things are fairly calm. It's more or less flat. Sure, we do have underlying inflation, but we can offset that by improving efficiency. As things stand, we don't see any specific headwinds ahead. The one note of caution I'd add is that nobody knows what Donald Trump might do next. I suppose that's fair enough — it's something everyone is worried about. All else being equal, we view the raw material situation and the shipping situation as being fairly calm.

Moderator

operator
#47

Also, Mark, I think you noted earlier that during the half, the mix included a greater share of lower-value products. Is there a particular reason for that, and could it carry over into the second half as well?

Mark Strickland

executive
#48

I wouldn’t worry too much about that being a lower headline price, since what really matters to us in the end is margin in pound notes. It’s going to depend on which retailer, which product sets, what we’ve won, what we’ve lost—lost, sorry. Our mix will always have a natural ebb and flow as it goes through. No, I don’t believe there’s anything—there’s certainly nothing that concerns me about our mix at this stage.

Moderator

operator
#49

I guess this ties in—and it's not really a question aimed at McBride—but somebody remarked, "Is there a continuing pattern where end consumers are basically receiving reduced volume in what they buy while paying more?" I guess all of that factors into, you know, the fight for market share among brands.

Christopher Ian Smith

executive
#50

So there's a bit of a trend—partly sustainability-driven, also transport cost and so on—toward compaction. And it varies quite a lot across Europe. For instance, if you purchase a laundry liquid in southern Spain, you may need weightlifting training just to carry your four-liter bottle home. The same number of washes in Germany or the U.K. comes in a one-liter bottle. When you make that switch, there's a perception—possibly a % perception—of a value gap, because what you're buying looks much smaller. I think it's the right thing to do, and we'll keep progressing that on sustainability grounds and pure. You know, we fit far more 1-liter bottles of laundry liquid in a lorry than four-liter bottles, right? Value too. For consumers, I think the value position is perhaps driven more by the quality of performance than by pure value position in price points on shelf. The reality is that private label keeps outperforming many of the brands in tests, and wider and wider audiences are learning that, and I think understanding that the value option does just as good a job, right?

Christopher Ian Smith

executive
#51

I think we'll keep championing private label overall — and naturally that includes McBride — by helping shoppers see the value. It isn't a product, if you'll pardon the phrase, for poor people. It's for smart people, since why pay double the price when your cleaning results don't get any better? By the way, most of what you purchase goes under the sink and you never glance at it again. You're not buying something lovely to look at. I think consumers are getting more savvy, and the retailers back that up with their proposition.

Moderator

operator
#52

To wrap up, maybe just 2 or so more questions of a strategic nature. Feel free to say as much as you want about what your different competitors are up to in certain divisions, and the same question applies to contract manufacturing.

Christopher Ian Smith

executive
#53

Look, overall I’d say the industry is fairly stable. In private label specifically, what we’re seeing right now is a pretty orderly situation. And look, all of us—if you look at that private label share chart I showed earlier, it moved from roughly 30%, 30%, 31% up to 36%, and you might think, “Well, that’s just 5% or 6% growth,” but in fact that 5% or 6% is on a base of 30, right? In private label, most of the major players are still active there. They’ve all grown along with that market, and I think all of us have been experiencing that. Of course, that helps when you’re a manufacturing business, right? Running volumes through manufacturing plants always helps with overhead costs and recoveries. I’d say there’s nothing particular to comment on. In contract manufacturing, obviously there’s been some publicity around Reckitt’s disposal of Essential Home to private equity owners. That is in transition right now, and it may create opportunity. At least on average across Europe—and to some extent in Asia—we are seeing more consideration of optionality around outsourcing, perhaps more than we’ve seen for a while.

Christopher Ian Smith

executive
#54

Perhaps I'll stop there, Andy.

Moderator

operator
#55

Alright, I think those are good notes to wrap up on. You kept referring back to really solid progress against the Capital Markets Day targets that were set a couple of years ago. There's a question: given that pace of progress, might you be revisiting some of those targets and setting further medium-term objectives in the not-too-distant future?

Christopher Ian Smith

executive
#56

Okay, so, yes — annually we review both our strategy and our targets. Naturally we won't be resetting those publicly each year, but at some stage we would of course revisit and refresh them. No timing has been fixed for that as yet. Actually, Mark and I discussed just yesterday when that point might come. Honestly, I strongly believe clarity about where the business is headed matters enormously — both for our own teams to grasp it and for customers and suppliers too. We stay watchful about adapting, correcting course, and closing gaps we believe we've overlooked, all the time. Those ambitions — our strategic ambitions — aren't something we leave untouched. Yes, at some stage, possibly within the coming year, we'll need to carry out that update and refresh. We feel very upbeat regarding the progress made. Our medium-term ambitions still require us to push on: revenues above GBP 1 billion, and EBITDA reaching 10%. Mark and I have consistently stated our wish to keep lifting EBITDA — double it again, correct?

Christopher Ian Smith

executive
#57

To pull that off, though, we'll likely require a larger train set than the one we currently have. And we're going to go about it in the proper, judicious manner, at the moment when the timing is right.

Moderator

operator
#58

Nicely put. Great! Well, let me thank everyone listening for their interest and for such a genuinely engaging set of questions. A feedback form will come your way once this event wraps up, and the company would be very pleased if you'd share your thoughts through it. As has already been noted, the deck being used sits on the McBride Investor Relations page, alongside plenty of other materials. On the subject of what lies ahead — something the company can't be too specific about — there is, of course, a recent Equity Development research note published following the interims, with, I'm happy to say, a raised fair value of 245 pence a share, which these two gentlemen are smiling at approvingly, and which I'd recommend you look over for further detail.

Moderator

operator
#59

And finally, of course, huge thanks to Chris and Mark, plus congratulations not just to the two of them but to the entire McBride team on the very impressive progress they've delivered over many years now, which we hope will carry on through the second half and beyond. Thanks for your time, gentlemen.

Christopher Ian Smith

executive
#60

Thanks.

Mark Strickland

executive
#61

Thanks as well. Appreciate it, everybody.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete McBride plc transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to McBride plc earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in McBride plc or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.